176 related articles for article (PubMed ID: 32905135)
21. UX007 for the treatment of long chain-fatty acid oxidation disorders: Safety and efficacy in children and adults following 24weeks of treatment.
Vockley J; Burton B; Berry GT; Longo N; Phillips J; Sanchez-Valle A; Tanpaiboon P; Grunewald S; Murphy E; Humphrey R; Mayhew J; Bowden A; Zhang L; Cataldo J; Marsden DL; Kakkis E
Mol Genet Metab; 2017 Apr; 120(4):370-377. PubMed ID: 28189603
[TBL] [Abstract][Full Text] [Related]
22. Effects of triheptanoin (UX007) in patients with long-chain fatty acid oxidation disorders: Results from an open-label, long-term extension study.
Vockley J; Burton B; Berry G; Longo N; Phillips J; Sanchez-Valle A; Chapman K; Tanpaiboon P; Grunewald S; Murphy E; Lu X; Cataldo J
J Inherit Metab Dis; 2021 Jan; 44(1):253-263. PubMed ID: 32885845
[TBL] [Abstract][Full Text] [Related]
23. Expanded molecular features of carnitine acyl-carnitine translocase (CACT) deficiency by comprehensive molecular analysis.
Wang GL; Wang J; Douglas G; Browning M; Hahn S; Ganesh J; Cox S; Aleck K; Schmitt ES; Zhang W; Wong LJ
Mol Genet Metab; 2011 Aug; 103(4):349-57. PubMed ID: 21605995
[TBL] [Abstract][Full Text] [Related]
24. Novel mutations associated with carnitine-acylcarnitine translocase and carnitine palmitoyl transferase 2 deficiencies in Malaysia.
Habib A; Azize NAA; Rahman SA; Yakob Y; Suberamaniam V; Nazri MIBA; Abdullah Sani H; Ch'ng GS; Yin LH; Olpin S; Lock-Hock N
Clin Biochem; 2021 Dec; 98():48-53. PubMed ID: 34626609
[TBL] [Abstract][Full Text] [Related]
25. Response to triheptanoin therapy in critically ill patients with LC-FAOD: Report of patients treated through an expanded access program.
Vockley J; Enns GM; Ramirez AN; Bedrosian CL; Reineking B; Lu X; Ray K; Rahman S; Marsden D
Mol Genet Metab; 2022 Jun; 136(2):152-162. PubMed ID: 35459555
[TBL] [Abstract][Full Text] [Related]
26. Assessing growth of infants with chylothorax receiving fortified skimmed human breast milk.
Clark B; Froh M; Karls C; Feuling MB; Goday P; Uhing M; Handler SS; Nghiem-Rao TH; Polzin E
Nutr Clin Pract; 2023 Feb; 38(1):199-203. PubMed ID: 35780315
[TBL] [Abstract][Full Text] [Related]
27. Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders.
Sklirou E; Alodaib AN; Dobrowolski SF; Mohsen AA; Vockley J
Front Genet; 2020; 11():598760. PubMed ID: 33584796
[TBL] [Abstract][Full Text] [Related]
28. Increased acylcarnitine ratio indices in newborn screening for carnitine-acylcarnitine translocase deficiency shows increased sensitivity and reduced false-positivity.
Shi C; Ao Z; Liu B; Xiao X; Gu X; Yang Q; Hao H; Cai Y; Li S
Transl Pediatr; 2023 May; 12(5):871-881. PubMed ID: 37305732
[TBL] [Abstract][Full Text] [Related]
29. Long-term experience with triheptanoin in 12 Austrian patients with long-chain fatty acid oxidation disorders.
Zöggeler T; Stock K; Jörg-Streller M; Spenger J; Konstantopoulou V; Hufgard-Leitner M; Scholl-Bürgi S; Karall D
Orphanet J Rare Dis; 2021 Jan; 16(1):28. PubMed ID: 33446227
[TBL] [Abstract][Full Text] [Related]
30. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
[TBL] [Abstract][Full Text] [Related]
31. Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening.
Shibata N; Hasegawa Y; Yamada K; Kobayashi H; Purevsuren J; Yang Y; Dung VC; Khanh NN; Verma IC; Bijarnia-Mahay S; Lee DH; Niu DM; Hoffmann GF; Shigematsu Y; Fukao T; Fukuda S; Taketani T; Yamaguchi S
Mol Genet Metab Rep; 2018 Sep; 16():5-10. PubMed ID: 29946514
[TBL] [Abstract][Full Text] [Related]
32. Identification of two novel mutations of the carnitine/acylcarnitine translocase (CACT) gene in a patient with CACT deficiency.
Ogawa A; Yamamoto S; Kanazawa M; Takayanagi M; Hasegawa S; Kohno Y
J Hum Genet; 2000; 45(1):52-5. PubMed ID: 10697964
[TBL] [Abstract][Full Text] [Related]
33. Dietary fat types differently modulate the activity and expression of mitochondrial carnitine/acylcarnitine translocase in rat liver.
Priore P; Stanca E; Gnoni GV; Siculella L
Biochim Biophys Acta; 2012 Oct; 1821(10):1341-9. PubMed ID: 22819991
[TBL] [Abstract][Full Text] [Related]
34. A novel SLC25A20 splicing mutation in patients of different ethnic origin with neonatally lethal carnitine-acylcarnitine translocase (CACT) deficiency.
Korman SH; Pitt JJ; Boneh A; Dweikat I; Zater M; Meiner V; Gutman A; Brivet M
Mol Genet Metab; 2006 Dec; 89(4):332-8. PubMed ID: 16919490
[TBL] [Abstract][Full Text] [Related]
35. Screening for newborn fatty acid oxidation disorders in Chongqing and the follow-up of confirmed children.
Chen M; Yin Y; Liu H; Peng Y; Ye L; Luo Q; Miao J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 51(3):290-297. PubMed ID: 36207828
[TBL] [Abstract][Full Text] [Related]
36. Three novel mutations in the carnitine-acylcarnitine translocase (CACT) gene in patients with CACT deficiency and in healthy individuals.
Fukushima T; Kaneoka H; Yasuno T; Sasaguri Y; Tokuyasu T; Tokoro K; Fukao T; Saito T
J Hum Genet; 2013 Dec; 58(12):788-93. PubMed ID: 24088670
[TBL] [Abstract][Full Text] [Related]
37. Functional analysis of mutant human carnitine acylcarnitine translocases in yeast.
IJlst L; van Roermund CW; Iacobazzi V; Oostheim W; Ruiter JP; Williams JC; Palmieri F; Wanders RJ
Biochem Biophys Res Commun; 2001 Jan; 280(3):700-6. PubMed ID: 11162577
[TBL] [Abstract][Full Text] [Related]
38. Functional analysis of mutations in the human carnitine/acylcarnitine translocase in Aspergillus nidulans.
Pérez P; Martínez O; Romero B; Olivas I; Pedregosa AM; Palmieri F; Laborda F; Ramón De Lucas J
Fungal Genet Biol; 2003 Aug; 39(3):211-20. PubMed ID: 12892634
[TBL] [Abstract][Full Text] [Related]
39. Heat stress deteriorates mitochondrial beta-oxidation of long-chain fatty acids in cultured fibroblasts with fatty acid beta-oxidation disorders.
Li H; Fukuda S; Hasegawa Y; Purevsuren J; Kobayashi H; Mushimoto Y; Yamaguchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1669-72. PubMed ID: 20207594
[TBL] [Abstract][Full Text] [Related]
40. New insights into carnitine-acylcarnitine translocase deficiency from 23 cases: Management challenges and potential therapeutic approaches.
Ryder B; Inbar-Feigenberg M; Glamuzina E; Halligan R; Vara R; Elliot A; Coman D; Minto T; Lewis K; Schiff M; Vijay S; Akroyd R; Thompson S; MacDonald A; Woodward AJM; Gribben JEL; Grunewald S; Belaramani K; Hall M; van der Haak N; Devanapalli B; Tolun AA; Wilson C; Bhattacharya K
J Inherit Metab Dis; 2021 Jul; 44(4):903-915. PubMed ID: 33634872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
